EKF Diagnostics Investor Announcements


EKF Diagnostics Holdings plc is an in-vitro diagnostics (IVD) business. The Company is engaged in the designing, development, manufacture and selling of diagnostic analyzers, reagents and ancillary products. This activity takes place across several geographical locations which include the United Kingdom, United States of America, Germany, Poland and Russia.

Standard form for notification of major holdings 

EKF Diagnostics announces an update to its prior announcement on 6 November 2015 in relation to the settlement agreement reached with the majority of the former shareholders of Selah.

Standard form for notification of major holdings 

11th Sep 2017

EKF Diagnostics Holdings plc announces its unaudited interim results for the six months ended 30 June 2017.

6th Sep 2017

EKF Diagnostics Holdings plc announces that the reduction of the Company's share capital has now been approved by the court.

EKF Diagnostics Holdings plc announces that it will release its interim results for the six months ended 30 June 2017 on Monday 11 September 2017.

Standard form for notification of major holdings

Standard form for notification of major holdings 

Resolutions to cancel the share premium account of the Company and to grant the Company the general authority to make market purchases of its own shares were passed.

Notification of major holdings.